Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;24(9):920-929.
doi: 10.2174/0115680096281906231213055422.

Recent Progress in the Application of Exosome Analysis in Ovarian Cancer Management

Vahideh Keyvani  1   2   3 , Zari Naderi Ghale-Noie  1 , Samaneh Mollazadeh  4 , Reihaneh Alsadat Mahmoudian  3   5   6 , Elnaz Ghorbani  3   7 , Hamid Naderi  3 , Majid Khazaei  3 , Seyed Mahdi Hassanian  3 , Gordon A Ferns  8 , Amir Avan  3   9   10 , Kazem Anvari  6
Affiliations
Review

Recent Progress in the Application of Exosome Analysis in Ovarian Cancer Management

Vahideh Keyvani et al. Curr Cancer Drug Targets. 2024.

Abstract

Exosomes are very small (nano-sized) vesicles participating in tumor development by involvement in intercellular communication mediated by transferring biocomponents. Exosomes appear to play vital roles in various cancer development, such as ovarian cancer, a common malignancy in women. Several hallmarks of ovarian cancer are reported to be affected by the exosomemediated cellular cross-talk, including modulating peritoneal dissemination and chemoresistance. Since the expression of some biomolecules, such as miRNAs and mRNA, is changed in ovarian cancer, these exo-biomolecules can be applied as prognostic, diagnostic, and therapeutic biomarkers. Also, the selective loading of specific chemotherapeutic agents into exosomes highlights these biocarries as potential delivery devices. Exosomes could be artificially provided and engineered to better target the site of interest in ovarian cancer. In the present review, we summarize the notable achievement of exosome application in ovarian cancer management to gain applicable transitional insight against this cancer.

Keywords: Ovarian cancer; bioactive molecules; biomarkers; delivery vehicles; exosomes; extracellular vesicles..

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Feng W.; Dean D.C.; Hornicek F.J.; Shi H.; Duan Z.; Exosomes promote pre-metastatic niche formation in ovarian cancer. Mol Cancer 2019,18(1),124 - DOI - PubMed
    1. Cabasag C.J.; Fagan P.J.; Ferlay J.; Vignat J.; Laversanne M.; Liu L.; van der Aa M.A.; Bray F.; Soerjomataram I.; Ovarian cancer today and tomorrow: A global assessment by world region and human development index using 2020. Int J Cancer 2022,151(9),1535-1541 - DOI - PubMed
    1. Xu Z.; Zeng S.; Gong Z.; Yan Y.; Inmunoterapia basada en exosomas: un enfoque prometedor para el tratamiento del cáncer. Mol Cancer 2020,19(1)
    1. Soleimani M.; Homayoun M.; Sajedi N.; In vitro evaluation of the pogostone effects on the expression of PTEN and DACT1 tumor suppressor genes, cell cycle, and apoptosis in ovarian cancer cell line. Res Pharm Sci 2022,17(2),164-175 - DOI - PubMed
    1. Lo Presti E.; Pizzolato G.; Corsale A.M.; Caccamo N.; Sireci G.; Dieli F.; Meraviglia S.; γδ T cells and tumor microenvironment: From immunosurveillance to tumor evasion. Front Immunol 2018,9,1395 - DOI - PubMed